OMB APPROVAL |
||||
OMB Number: 3235-0145 |
||||
Expires: February 28, 2009 |
||||
Estimated average burden hours per response...10.4 |
||||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
o Rule 13d-1(c)
þ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM BioVentures III, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 232,263* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 232,263* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
232,263* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
1.4% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 2 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM BioVentures III-QP, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 3,454,509* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 3,454,509* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
3,454,509* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
21.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 3 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM BioVentures III Parallel Fund, LP |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 104,362* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 104,362* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
104,362* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0.6% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 4 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM BioVentures III GmbH & Co. Beteiligungs KG |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Germany | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 291,917* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 291,917* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
291,917* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
1.8% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 5 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM Asset Management Investors 2002 BVIII LLC |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 68,246* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 68,246* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
68,246* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0.4% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 6 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM BioVentures III GP, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,083,051* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,083,051* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,083,051* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 7 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) MPM BioVentures III LLC |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,083,051* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,083,051* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,083,051* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 8 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Ansbert Gadicke |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,151,297* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 9 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Luke Evnin |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 7,812* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297** | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 7,812* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297** | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,159,109* ** | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 10 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Nicholas Galakatos |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,151,297* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 11 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Michael Steinmetz |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,151,297* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 12 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Kurt Wheeler |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297** | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,151,297* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 13 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Nicholas Simon III |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,151,297* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 14 of 24
CUSIP No. |
29365M 109 |
1 | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY) Dennis Henner |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 4,151,297* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
4,151,297* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
4,151,297* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
25.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 15 of 24
(a) | Name of Issuer |
(b) | Address of Issuers Principal Executive Offices |
(a) | Name of Person Filing |
(b) | Address of Principal Business Office or, if none, Residence |
(c) | Citizenship |
(d) | Title of Class of Securities |
(e) | CUSIP Number |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Page 16 of 24
(a) | Amount Beneficially Owned: |
MPM BioVentures III, L.P. |
232,263 | (1) | ||
MPM BioVentures III-QP, L.P. |
3,454,509 | (2) | ||
MPM BioVentures III Parallel Fund, L.P. |
104,362 | (3) | ||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
291,917 | (4) | ||
MPM Asset Management Investors 2002 BVIII LLC |
68,246 | (5) | ||
MPM BioVentures III GP, L.P. |
4,083,051 | (6) | ||
MPM BioVentures III LLC |
4,083,051 | (7) | ||
Ansbert Gadicke |
4,151,297 | (8) | ||
Luke Evnin |
4,159,109 | (6)(9) | ||
Nicholas Galakatos |
4,151,297 | (8) | ||
Michael Steinmetz |
4,151,297 | (8) | ||
Kurt Wheeler |
4,151,297 | (8) | ||
Nicholas Simon III |
4,151,297 | (8) | ||
Dennis Henner |
4,151,297 | (8) |
Percent of Class: |
MPM BioVentures III, L.P. |
1.4 | % | ||
MPM BioVentures III-QP, L.P. |
21.0 | % | ||
MPM BioVentures III Parallel Fund, L.P. |
0.6 | % | ||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
1.8 | % | ||
MPM Asset Management Investors 2002 BVIII LLC |
0.4 | % | ||
MPM BioVentures III GP, L.P. |
25.0 | % | ||
MPM BioVentures III LLC |
25.0 | % | ||
Ansbert Gadicke |
25.5 | % | ||
Luke Evnin |
25.5 | % | ||
Nicholas Galakatos |
25.5 | % | ||
Michael Steinmetz |
25.5 | % | ||
Kurt Wheeler |
25.5 | % | ||
Nicholas Simon III |
25.5 | % | ||
Dennis Henner |
25.5 | % |
Page 17 of 24
(b) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote |
MPM BioVentures III, L.P. |
232,263 | (1) | ||
MPM BioVentures III-QP, L.P. |
3,454,509 | (2) | ||
MPM BioVentures III Parallel Fund, L.P. |
104,362 | (3) | ||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
291,917 | (4) | ||
MPM Asset Management Investors 2002 BVIII LLC |
68,246 | (5) | ||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
7,812 | (9) | ||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 | |||
Nicholas Simon III |
0 | |||
Dennis Henner |
0 |
(ii) | Shared power to vote or to direct the vote |
MPM BioVentures III, L.P. |
0 | |||
MPM BioVentures III-QP, L.P. |
0 | |||
MPM BioVentures III Parallel Fund, L.P. |
0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2002 BVIII LLC |
0 | |||
MPM BioVentures III GP, L.P. |
4,083,051 | (6) | ||
MPM BioVentures III LLC |
4,083,051 | (7) | ||
Ansbert Gadicke |
4,151,297 | (8) | ||
Luke Evnin |
4,151,297 | (8) | ||
Nicholas Galakatos |
4,151,297 | (8) | ||
Michael Steinmetz |
4,151,297 | (8) | ||
Kurt Wheeler |
4,151,297 | (8) | ||
Nicholas Simon III |
4,151,297 | (8) | ||
Dennis Henner |
4,151,297 | (8) |
Page 18 of 24
(iii) | Sole power to dispose or to direct the disposition of |
MPM BioVentures III, L.P. |
232,263 | (1) | ||
MPM BioVentures III-QP, L.P. |
3,454,509 | (2) | ||
MPM BioVentures III Parallel Fund, L.P. |
104,362 | (3) | ||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
291,917 | (4) | ||
MPM Asset Management Investors 2002 BVIII LLC |
68,246 | (5) | ||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
7,812 | (9) | ||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 | |||
Nicholas Simon III |
0 | |||
Dennis Henner |
0 |
(iv) | Shared power to dispose or to direct the disposition of |
MPM BioVentures III, L.P. |
0 | |||
MPM BioVentures III-QP, L.P. |
0 | |||
MPM BioVentures III Parallel Fund, L.P. |
0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2002 BVIII LLC |
0 | |||
MPM BioVentures III GP, L.P. |
4,083,051 | (6) | ||
MPM BioVentures III LLC |
4,083,051 | (7) | ||
Ansbert Gadicke |
4,151,297 | (8) | ||
Luke Evnin |
4,151,297 | (8) | ||
Nicholas Galakatos |
4,151,297 | (8) | ||
Michael Steinmetz |
4,151,297 | (8) | ||
Kurt Wheeler |
4,151,297 | (8) | ||
Nicholas Simon III |
4,151,297 | (8) | ||
Dennis Henner |
4,151,297 | (8) |
(1) | Includes 7,047 shares issuable pursuant to warrants exercisable within 60 days of December 31, 2007. | |
(2) | Includes 104,814 shares issuable pursuant to warrants exercisable within 60 days of December 31, 2007. | |
(3) | Includes 3,166 shares issuable pursuant to warrants exercisable within 60 days of December 31, 2007. | |
(4) | Includes 8,857 shares issuable pursuant to warrants exercisable within 60 days of December 31, 2007. | |
(5) | Includes 2,070 shares issuable pursuant to warrants exercisable within 60 days of December 31, 2007. | |
(6) | The shares are held as follows: 3,349,695 by MPM BioVentures III-QP, L.P. (BV III QP), 225,216 by MPM BioVentures III, L.P. (BV III), 101,196 by MPM BioVentures III Parallel Fund, L.P. (BV III PF) and 283,060 by MPM BioVentures III GmbH & Co. Beteiligungs KG (BV III KG). Also includes warrants exercisable within 60 days of December 31, 2007 as follows: 104,814 by BV III QP, 7,047 by BV III, 3,166 by BV III PF and 8,857 by BV III KG. The Reporting Person is the direct general partner of BV III, BV III QP, BV III PF and BV III KG. | |
(7) | The shares are held as follows: 3,349,695 by BV III QP, 225,216 by BV III, 101,196 by BV III PF and 283,060 by BV III KG. Also includes warrants exercisable within 60 days of December 31, 2007 as follows: 104,814 by BV III QP, 7,047 by BV III, 3,166 by BV III PF and 8,857 by BV III KG. The Reporting Person is the indirect general partner of BV III, BV III QP, BV III PF and BV III KG. | |
(8) | The shares are held as follows: 3,349,695 by BV III QP, 225,216 by BV III, 66,176 by MPM Asset Management Investors 2002 BVIII LLC (BV AM LLC), 101,196 by BV III PF and 283,060 by BV III KG. Also includes warrants exercisable within 60 days of December 31, 2007 as follows: 104,814 by BV III QP, 7,047 by BV III, 2,070 by BV AM LLC, 3,166 by BV III PF and 8,857 by BV III KG. MPM BioVentures III GP, L.P. (BV III GP) and MPM BioVentures III LLC (BV III LLC) are the direct and indirect general partners of BV III, BV III QP, BV III PF and BV III KG. The Reporting Person is a member of BV III LLC and BV AM LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein. | |
(9) | Includes 7,812 shares issuable upon exercise of options within 60 days of December 31, 2007 |
Page 19 of 24
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Page 20 of 24
MPM BIOVENTURES III, L.P. | MPM BIOVENTURES III-QP, L.P. | |||||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||||
its General Partner | its General Partner | |||||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||||
its General Partner | its General Partner | |||||||
By:
|
/s/ Luke Evnin | By: | /s/ Luke Evnin | |||||
Name: Luke Evnin | Name: Luke Evnin | |||||||
Title: Series A Member | Title: Series A Member | |||||||
MPM BIOVENTURES III PARALLEL FUND, L.P. | MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |||||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||||
its General Partner | in its capacity as the Managing Limited Partner | |||||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||||
its General Partner | its General Partner | |||||||
By:
|
/s/ Luke Evnin | By: | /s/ Luke Evnin | |||||
Name: Luke Evnin | Name: Luke Evnin | |||||||
Title: Series A Member | Title: Series A Member | |||||||
MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC |
MPM BIOVENTURES III GP, L.P. | |||||||
By: | MPM BioVentures III LLC, | |||||||
By:
|
/s/ Luke Evnin | its General Partner | ||||||
Name: Luke Evnin | ||||||||
Title: Manager | By: | /s/ Luke Evnin | ||||||
Name: Luke Evnin | ||||||||
Title: Series A Member | ||||||||
MPM BIOVENTURES III LLC | ||||||||
By:
|
/s/ Luke Evnin | By: | /s/ Ansbert Gadicke | |||||
Name: Luke Evnin | Name: Ansbert Gadicke | |||||||
Title: Series A Member |
Page 21 of 24
By:
|
/s/ Luke Evnin | By: | /s/ Nicholas Galakatos | |||||
Name: Luke Evnin | Name: Nicholas Galakatos | |||||||
By:
|
/s/ Michael Steinmetz | By: | /s/ Kurt Wheeler | |||||
Name: Michael Steinmetz | Name: Kurt Wheeler | |||||||
By:
|
/s/ Nicholas Simon III | By: | /s/ Dennis Henner | |||||
Name: Nicholas Simon III | Name: Dennis Henner |
Page 22 of 24
MPM BIOVENTURES III, L.P. | MPM BIOVENTURES III-QP, L.P. | |||||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||||
its General Partner | its General Partner | |||||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||||
its General Partner | its General Partner | |||||||
By:
|
/s/ Luke Evnin | By: | /s/ Luke Evnin | |||||
Name: Luke Evnin | Name: Luke Evnin | |||||||
Title: Series A Member | Title: Series A Member | |||||||
MPM BIOVENTURES III PARALLEL FUND, L.P. | MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |||||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||||
its General Partner | in its capacity as the Managing Limited Partner | |||||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||||
its General Partner | its General Partner | |||||||
By:
|
/s/ Luke Evnin | By: | /s/ Luke Evnin | |||||
Name: Luke Evnin | Name: Luke Evnin | |||||||
Title: Series A Member | Title: Series A Member | |||||||
MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC |
MPM BIOVENTURES III GP, L.P. | |||||||
By: | MPM BioVentures III LLC, | |||||||
By:
|
/s/ Luke Evnin | its General Partner | ||||||
Name: Luke Evnin | ||||||||
Title: Manager | By: | /s/ Luke Evnin | ||||||
Name: Luke Evnin | ||||||||
Title: Series A Member | ||||||||
MPM BIOVENTURES III LLC | ||||||||
By:
|
/s/ Luke Evnin | By: | /s/ Ansbert Gadicke | |||||
Name: Luke Evnin | Name: Ansbert Gadicke | |||||||
Title: Series A Member |
Page 23 of 24
By:
|
/s/ Luke Evnin | By: | /s/ Nicholas Galakatos | |||||
Name: Luke Evnin | Name: Nicholas Galakatos | |||||||
By:
|
/s/ Michael Steinmetz | By: | /s/ Kurt Wheeler | |||||
Name: Michael Steinmetz | Name: Kurt Wheeler | |||||||
By:
|
/s/ Nicholas Simon III | By: | /s/ Dennis Henner | |||||
Name: Nicholas Simon III | Name: Dennis Henner |
Page 24 of 24